The skin-body crosstalk

Skin health is whole-body health

The skin-body crosstalk: how systemic aging shapes skin, and how aging skin feeds back into the body.

Key points

• Skin is not a wrapper. It holds nearly twice as many T cells as the blood, runs its own version of the stress-hormone axis, and can change blood pressure.
• Systemic aging writes itself into skin. Blood glucose, menopause, psychological stress, sleep, and gut signals all change skin in measurable ways.
• Skin talks back. In aged mice, a failing barrier raises circulating inflammatory cytokines. In older adults, barrier repair lowered them.
• Inflammatory skin disease shows how far the signal travels. Severe psoriasis and eczema carry higher cardiovascular risk, and treating psoriasis has been linked to less coronary inflammation.
• Skin is also a readout. How old a face looks, and how much glycation skin has accumulated, predict cardiovascular disease and mortality.
• Skin longevity is part of systemic longevity. The interface is accessible, measurable, and worth treating that way.

An organ that talks back

Medicine has long treated skin as a mirror: inner health shows on the surface. That view is right, but incomplete. Skin does not only reflect the body. It signals to it.

Skin makes up about 15% of adult body weight [1]. It is the body's largest interface with the environment and one of its largest immune organs. It produces hormones, senses stress, influences blood pressure, and sends inflammatory signals into the circulation. As it ages, those signals change. The field now recognizes that skin aging and systemic aging influence each other in both directions [2].

This essay follows the traffic both ways: how systemic aging shapes skin, how aging skin feeds back into the body, and what that means for anyone who treats skin as part of healthspan rather than apart from it. It also separates what is established from what is still a hypothesis.

Systemic aging reaches skin through blood, hormones, and nerves. Skin answers with immune, endocrine, and vascular signals of its own, and what it carries can be read as a measure of systemic aging.

Far more than a wrapper

Three facts set the scale of what skin can do to the rest of the body.

It is a major immune organ. Normal, uninflamed human skin holds about one million T cells per square centimeter, an estimated 20 billion in total. That is nearly twice the number circulating in the blood. Roughly 98% of the skin-homing effector memory T cells in the body live in skin at rest [3].

It runs its own stress axis. Skin produces corticotropin-releasing hormone, proopiomelanocortin, and their receptors, organized as a local equivalent of the hypothalamic-pituitary-adrenal axis [4]. The local system is wired to the central one. In mice, a single dose of ultraviolet B to the skin raised corticotropin-releasing hormone, ACTH, β-endorphin, and corticosterone in brain and plasma within 30 to 90 minutes, and suppressed immune responses in the spleen [5].

It talks to the vasculature. Skin stores nitric oxide. In 24 healthy volunteers, ultraviolet A on the skin released those stores into the circulation, increased blood flow, and lowered blood pressure [6].

An organ with this much immune, endocrine, and vascular reach cannot age in isolation.

Body to skin: how systemic aging writes itself into skin

Much of what ages skin starts elsewhere and arrives through the blood, the hormones, and the nervous system.

Metabolism. In the Leiden Longevity Study, perceived age rose by 0.4 years for every 1 mmol/L increase in serum glucose, even in people without diabetes [7]. In diabetes, glycation products accumulate faster in skin collagen [8], where a protein that turns over once in a decade or more carries the damage for years.

Hormones. After menopause, skin collagen content and skin thickness decline by 1% to 2% a year, in step with bone mass. The parallel suggests a shared loss in the connective tissue common to both [9].

Psychological stress. In 27 medical, dental, and pharmacy students, barrier recovery after tape stripping slowed during final examinations and recovered once the stress passed. The largest increases in perceived stress went with the largest losses of barrier function [10].

Sleep. Women who chronically slept poorly had higher intrinsic aging scores, 30% less barrier recovery at 72 hours, and slower recovery from ultraviolet-induced redness than good sleepers [11].

The gut. The gut microbiome communicates with skin, influencing keratinocyte differentiation and cutaneous immune responses [12].

Inflammaging. The chronic, low-grade inflammation that rises with age throughout the body [13] reaches skin through the same circulation that feeds it.

None of these signals starts in skin. All of them show up in it.

Skin to body: how aging skin feeds back

The more surprising half of the crosstalk runs outward. Aging skin does not only receive systemic signals. It produces them.

The barrier as a source of inflammaging

The aging epidermal barrier is less resilient: it is breached more easily and recovers more slowly. In mice, that weakness has systemic consequences. Acute barrier disruption raised serum cytokine levels. Aged mice had elevated cytokines in both skin and blood, and correcting epidermal function brought the serum levels down [14].

The same pattern has been seen in people. In a pilot study of 33 older adults, 30 days of a twice-daily topical emollient improved barrier function, normalized circulating IL-1β and IL-6, and substantially lowered TNF-α [15]. The researchers behind this work propose that epidermal dysfunction is one contributor to inflammaging, and have linked chronic skin inflammation to cognitive decline [16].

A skin-born signal that reprograms a distant organ

The clearest demonstration that skin can set the tone of another organ comes from the atopic march, the progression from eczema to asthma. In mice with barrier defects, keratinocytes overproduce the alarmin TSLP, which reaches the circulation and sensitizes the lungs to allergic asthma. Blocking TSLP signaling stopped the progression, and TSLP from the epidermis alone was enough to cause it [17]. A signal made in skin set up disease in the lung.

Senescence beyond the skin

Senescent cells accumulate in aging skin and secrete an inflammatory, matrix-degrading program. In mice, transplanting relatively small numbers of senescent cells was enough to cause persistent physical dysfunction and to spread senescence into host tissues [18]. That establishes the principle that senescent cells can act at a distance. Whether the senescent burden of human skin contributes to systemic aging has not yet been measured. It is a plausible route, not a proven one.

Stress signals from the surface

Skin also signals through the nervous and endocrine systems. In mice, ultraviolet exposure of the skin activates the central stress axis within minutes, with systemic immune effects [5]. Skin is a sensor that reports to the brain, not only a target the brain acts on.

The proof case: inflammatory skin disease

The strongest human evidence that skin inflammation travels comes from disease, where the signal is loud enough to measure at population scale.

Psoriasis. In a UK cohort of more than 130,000 patients with psoriasis and over 550,000 controls, psoriasis was an independent risk factor for myocardial infarction after adjusting for hypertension, diabetes, lipids, smoking, and body mass index. For a 30-year-old with severe psoriasis, the adjusted relative risk was 3.1. At 60, it was 1.36 [19].

Atopic eczema. Among 387,439 adults with eczema matched to more than 1.5 million controls, severe eczema carried a 40% to 50% higher risk of myocardial infarction, unstable angina, atrial fibrillation, and cardiovascular death, and a 70% higher risk of heart failure. Risk rose with severity and with how much of the time the disease was active [20].

Treatment. In 134 patients with moderate to severe psoriasis, one year of biologic therapy reduced coronary inflammation, measured by perivascular fat attenuation on CT angiography, alongside improvement in the skin. Patients treated only with topicals or light therapy showed no change [21]. Biologics act systemically, so this does not isolate the skin as the source. It does show that the inflammatory link between skin and arteries can be moved.

These are diseases, not ordinary aging. But they show the principle at scale: inflammation that starts in skin does not stay there. Aging skin carries a quieter, chronic version of the same load, across the body's largest surface, for decades.

Skin as a readout of systemic aging

If skin and body age together, skin should carry information about the body. It does, and the signal is strong enough to predict outcomes.

How old you look predicts how long you live. In 1,826 Danish twins aged 70 and older, perceived age from a photograph predicted survival after adjusting for chronological age, sex, and rearing environment. The older-looking twin was more likely to die first, and perceived age tracked physical function, cognition, and leucocyte telomere length [22].

Appearance tracks cardiovascular risk. In the Leiden Longevity Study, offspring of long-lived families had less wrinkling on sun-protected skin, and women in the lowest quartile of cardiovascular risk looked more than two years younger than those at higher risk, independent of age, smoking, sun damage, and body mass index [23].

Glycation in skin predicts disease. Skin autofluorescence is a non-invasive optical measure of advanced glycation end products accumulated in skin. In 72,880 participants of the Dutch Lifelines cohort, it predicted new type 2 diabetes, cardiovascular disease, and death over about four years, independent of blood glucose, HbA1c, and the metabolic syndrome [24].

Senescent cells in skin track biological age. People from long-lived families carry fewer p16INK4a-positive senescent cells in their skin [25]. In sun-protected arm skin, people with the fewest p16INK4a-positive epidermal cells looked three years younger than those with the most, independent of chronological age [26].

Skin is the most accessible tissue in the body. It can be photographed, scanned, and sampled without surgery. These studies show that what it carries reflects systemic aging well enough to predict disease and death.

Intervening at the interface

The practical question is whether improving skin can move systemic markers. Three lines of evidence say it can, at least in specific settings.

• Barrier repair in aged mice lowered elevated serum cytokines [14].
• Barrier repair in older adults normalized circulating IL-1β and IL-6 and lowered TNF-α in 30 days, in a small pilot [15].
• Treating skin inflammation in psoriasis was associated with less coronary inflammation, alongside clearer skin [21].

None of these was a study of ordinary skin aging treated from within. Together, they make the case that skin is a credible intervention point for systemic aging, not only a place where aging becomes visible. It is accessible, it can be measured, and changes in it can carry beyond it.

This is the premise behind treating skin longevity as part of systemic longevity. Support the cellular systems that keep skin renewing, the barrier sealed, and its inflammatory output low, and you are working on an interface the whole body depends on. Whether doing that from within measurably lowers systemic inflammatory tone in healthy aging adults is a testable question. It is the kind of question product-specific studies need to answer, and we intend to answer it.

What is established, and what is still a hypothesis

The skin-body crosstalk is real. Its strength varies by claim.

Claim	Evidence	Status
Systemic metabolism, hormones, stress, and sleep change skin	Human cohort and experimental studies	Established
Skin is a major immune and neuroendocrine organ	Human tissue studies, mouse physiology	Established
Skin appearance and skin glycation predict systemic disease and death	Large prospective human cohorts	Established association
Inflammatory skin disease raises cardiovascular risk	Population cohorts of hundreds of thousands	Established association
A failing barrier raises circulating inflammation with age	Mouse experiments, one human pilot	Emerging
Skin-born signals can drive disease in a distant organ	Mouse models of the atopic march	Shown in animals
Senescent cells in skin contribute to systemic aging	Mouse transplant studies; not yet measured from human skin	Hypothesis
Supporting aging skin from within lowers systemic inflammation	Not yet tested	Hypothesis

 

The direction of travel is clear. Skin is not a passive display of systemic health. It is a participant in it. Caring for skin's longevity is, in part, caring for the body's.

References

1. Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol. 2002;12(4):390–399.
2. Furman D, Auwerx J, Bulteau AL, et al. Skin health and biological aging. Nat Aging. 2025;5(7):1195–1206. doi
3. Clark RA, Chong B, Mirchandani N, et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol. 2006;176(7):4431–4439. doi
4. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979–1020. doi
5. Skobowiat C, Postlethwaite AE, Slominski AT. Skin exposure to ultraviolet B rapidly activates systemic neuroendocrine and immunosuppressive responses. Photochem Photobiol. 2017;93(4):1008–1015. doi
6. Liu D, Fernandez BO, Hamilton A, et al. UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol. 2014;134(7):1839–1846. doi
7. Noordam R, Gunn DA, Tomlin CC, et al. High serum glucose levels are associated with a higher perceived age. Age (Dordr). 2013;35(1):189–195. doi
8. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91(6):2463–2469. doi
9. Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet Gynecol. 1987;70(6):840–845.
10. Garg A, Chren MM, Sands LP, et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol. 2001;137(1):53–59. doi
11. Oyetakin-White P, Suggs A, Koo B, et al. Does poor sleep quality affect skin ageing? Clin Exp Dermatol. 2015;40(1):17–22. doi
12. Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459. doi
13. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi
14. Hu L, Mauro TM, Dang E, et al. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137(6):1277–1285. doi
15. Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197–2201. doi
16. Wen S, Elias PM, Wakefield JS, Mauro TM, Man MQ. The link between cutaneous inflammation and cognitive impairment. J Eur Acad Dermatol Venereol. 2022;36(10):1705–1712. doi
17. Demehri S, Morimoto M, Holtzman MJ, Kopan R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol. 2009;7(5):e1000067. doi
18. Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):1246–1256. doi
19. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741. doi
20. Silverwood RJ, Forbes HJ, Abuabara K, et al. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ. 2018;361:k1786. doi
21. Elnabawi YA, Oikonomou EK, Dey AK, et al. Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index. JAMA Cardiol. 2019;4(9):885–891. doi
22. Christensen K, Thinggaard M, McGue M, et al. Perceived age as clinically useful biomarker of ageing: cohort study. BMJ. 2009;339:b5262. doi
23. Gunn DA, de Craen AJ, Dick JL, et al. Facial appearance reflects human familial longevity and cardiovascular disease risk in healthy individuals. J Gerontol A Biol Sci Med Sci. 2013;68(2):145–152. doi
24. van Waateringe RP, Fokkens BT, Slagter SN, et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia. 2019;62(2):269–280. doi
25. Waaijer MEC, Parish WE, Strongitharm BH, et al. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012;11(4):722–725. doi
26. Waaijer MEC, Gunn DA, Adams PD, et al. P16INK4a positive cells in human skin are indicative of local elastic fiber morphology, facial wrinkling, and perceived age. J Gerontol A Biol Sci Med Sci. 2016;71(8):1022–1028. doi